Found 40 Enz. Inhib. hit(s) with Target = 'Peroxisome proliferator-activated receptor gamma [205-505]' TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.80E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.10E+4nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.70E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 6.00E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.80E+4nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.70E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 2.50E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 930nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 2.10E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 810nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 58nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 30nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 110nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 840nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.80E+4nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 470nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 72nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.80E+4nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 53nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 5.20nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 43nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 73nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.40E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 2.50E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 760nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.70E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 3.50E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 3.00E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.80E+4nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.50E+4nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 6.00E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 7.00E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 3.90E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 9.00E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.80E+4nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 8.20E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 3.80E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 4.20E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 4.20E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma [205-505](Homo sapiens (Human))
Albireo
US Patent
Albireo
US Patent
Affinity DataEC50: 1.70E+3nMAssay Description:Transactivation Assay Expression vectors were prepared by inserting the ligand binding domain cDNA (complementary DNA) of human PPARalpha (amino acid...More data for this Ligand-Target Pair
